Approved for Maintenance treatment of asthma in patients aged 12 years and older, Maintenance treatment of airflow obstruction in COPD. Combines fluticasone (inhaled corticosteroid) and salmeterol (long-acting beta-2 agonist). Fluticasone reduces airway inflammation while salmeterol provides sustained bronchodilation through beta-2… Side effects, costs, interactions, manufacturer, and generic…
Loading full data from Know Your Drugs Institute…